• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Novo Nordisk recalls cartridge holders in insulin delivery devices

July 6, 2017 By Sarah Faulkner

Novo Nordisk penNovo Nordisk (NYSE:NVO) launched a recall yesterday of insulin cartridge holders used in select batches of NovoPen Echo insulin delivery devices. The company said the cartridge holders could crack or break upon exposure to certain chemicals.

Using a NovoPen Echo with a cracked or broken cartridge holder could result in the device delivering a lower dose of insulin than the user intended.

The company said it “believes the risk of experiencing high blood sugar when using a device with an affected cartridge holder is low.”

The affected batches were distributed between August 1, 2016 and June 22, 2017 and include U.S. batch numbers EVG1221, EVG1226, FVG7149, FVG7458, FVG8134 and FVG8135.

Nordisk said that anyone with a device from the affected batches should contact the company for a replacement cartridge holder. Nordisk has received a number of complaints related to the damaged cartridge holders and has also received some reports of adverse events, according to the company.

“Novo Nordisk is committed to delivering high-quality products and sincerely apologizes to patients and health care professionals,” the company wrote in a statement. “We are working closely with the U.S Food and Drug Administration to ensure patient safety and further minimize disruption.”

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals, Recalls, Wall Street Beat Tagged With: Novo Nordisk

IN CASE YOU MISSED IT

  • Shareholder lawsuit over BD’s Alaris pumps recall moves forward
  • Embecta stock soars on first full-quarter results after BD spinoff
  • Abbott will spend $450M to up FreeStyle Libre production in Ireland
  • Better Therapeutics Q2 beats Street as it prepares to submit diabetes therapy for FDA review
  • Study backs Fluidx embolic device for vessel filling

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS